Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3276816
Max Phase: Preclinical
Molecular Formula: C21H27N3O
Molecular Weight: 337.47
Molecule Type: Small molecule
Associated Items:
ID: ALA3276816
Max Phase: Preclinical
Molecular Formula: C21H27N3O
Molecular Weight: 337.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)CCN1CCN(c2ccccc2)c2ccccc2C1=O
Standard InChI: InChI=1S/C21H27N3O/c1-3-22(4-2)14-15-23-16-17-24(18-10-6-5-7-11-18)20-13-9-8-12-19(20)21(23)25/h5-13H,3-4,14-17H2,1-2H3
Standard InChI Key: DUKOQRXNBYNJED-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 337.47 | Molecular Weight (Monoisotopic): 337.2154 | AlogP: 3.62 | #Rotatable Bonds: 6 |
Polar Surface Area: 26.79 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.01 | CX LogP: 3.50 | CX LogD: 1.88 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.81 | Np Likeness Score: -1.16 |
1. Bagolini C, de Witt P, Pacifici L, Ramacci MT.. (1978) Synthesis and pharmacological activity and some derivatives of 1-phenyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one., 21 (5): [PMID:26804] [10.1021/jm00203a015] |
Source(1):